Key result
A 3-gene nomogram model demonstrates excellent diagnostic performance for STEMI with an AUC of ~0.97.
Why the study?
STEMI involves complex molecular mechanisms potentially linked to brown adipocyte biology, but the specific brown adipocyte-related key genes and their roles in STEMI progression remain to be identified.
Population
STEMI patients and stable CAD controls from GEO datasets plus an independent clinical cohort of n = 5 per group
Comparison
STEMI vs stable CAD controls
Design
Bioinformatic transcriptomic analysis and machine learning study with RT-qPCR clinical cohort validation
Authors
Loading...
BA-related gene signatures may aid STEMI biomarker discovery; leaves open causal roles and clinical translation.
Observational (n=10)
Effect estimate: AUC 0.973
ASGR2, MCEMP1, and PPARG were identified as brown adipocyte-associated key genes upregulated in STEMI, showing excellent diagnostic potential and immune-metabolic relevance.
Li et al. (2026) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=10). ST-segment elevation myocardial infarction (STEMI) vs. Stable coronary artery disease (CAD) was evaluated on Diagnostic performance of a 3-gene nomogram model (AUC 0.973). A nomogram model incorporating brown adipocyte-related genes ASGR2, MCEMP1, and PPARG demonstrated excellent diagnostic performance for STEMI, achieving an AUC of 0.973.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: